| Company/Division name | Mayne Pharma |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 110 |
| Year reshoring announced: | 2015 |
| Year reshoring implemented or to be implemented: | 2018 |
| Capital investment ($): | 65 |
| Country(ies) from which reshored: | Australia |
| City reshored to: | Greenville |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals, oral-dose |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Under-utilized capacity |
